desmopressin acetate
Desmopressin Acetate Injection, USPFor Intravenous or Subcutaneous Use Only
Approved
Approval ID
40752c75-d09b-4013-9024-442048145b63
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Aug 14, 2020
Manufacturers
FDA
Sagent Pharmaceuticals
DUNS: 796852890
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
desmopressin acetate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code25021-461
Application NumberANDA204751
Product Classification
M
Marketing Category
C73584
G
Generic Name
desmopressin acetate
Product Specifications
Route of AdministrationINTRAVENOUS, SUBCUTANEOUS
Effective DateAugust 14, 2020
FDA Product Classification
INGREDIENTS (4)
hydrochloric acidInactive
Code: QTT17582CB
Classification: IACT
chlorobutanolInactive
Code: HM4YQM8WRC
Classification: IACT
sodium chlorideInactive
Code: 451W47IQ8X
Classification: IACT
desmopressin acetateActive
Quantity: 40 ug in 10 mL
Code: XB13HYU18U
Classification: ACTIB